04/08/2026
Excited to be a part of the Profound Autism Summit! We’re looking forward to sharing how biology- based insights can help inform earlier understanding of autism risk and support more proactive care.
Waiting for autism's behavioral symptoms to appear isn't the only option anymore. A breakthrough calcium signaling biomarker can detect ASD risk from infancy — with accuracy comparable to the ADOS based on company data. Jill S. Dolinsky, VP of Medical Sciences at NeuroQure, will explore how this could redefine developmental monitoring, early intervention and family counseling. Don't miss this session at the Profound Autism Summit! There's still time to register for in-person or the virtual option! Go to profoundautismsummit.org or the link in our bio.
.lab .aba